SYDNEY, Aug. 2, 2023 /PRNewswire/ — Arbele, a clinical-stage biotechnology company developing novel immunotherapies targeted for advanced gastrointestinal cancers, presented early safety data from its first-in-class CDH17xCD3 bispecific T-cell engager antibody, ARB202, at the ASCO…

SYDNEY, Aug. 2, 2023 /PRNewswire/ — Arbele, a clinical-stage biotechnology company developing novel immunotherapies targeted for advanced gastrointestinal cancers, presented early safety data from its first-in-class CDH17xCD3 bispecific T-cell engager antibody, ARB202, at the ASCO…

LONDON, Aug. 2, 2023 /PRNewswire/ — Avon Products, Inc. (“Avon,” the “Company” or “we”) announced today the early tender results in connection with its previously announced offer to purchase for cash (the “Tender Offer”) any and all of its outstanding 6.950% Notes due 2043 (the “Notes”)…

SAN DIEGO, Aug. 2, 2023 /PRNewswire/ — The law firm of Robbins Geller Rudman & Dowd LLP has launched an investigation into potential violations of U.S. federal securities laws involving Xponential Fitness, Inc. (NYSE: XPOF) focused on whether Xponential Fitness and certain of its top…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.